ER+/PR+ breast cancer is a subtype of ER positive breast cancer where the tumor cells express both estrogen receptors (ER) and progesterone receptors (PR) on the surface. As the most common type of ...

Metastatic breast cancer subtypes and biomarkers are crucial for guiding treatment decisions and managing disease progression. ER-positive, HER2-negative breast cancer treatment often begins with ...

Triple Negative Breast Cancer (TNBC) is one of the most aggresive types of breast cancer. It’s the kind of breast cancer that doesn’t have estrogen receptors, progesterone receptors, and human ...

NEW YORK — Research from Weill Cornell Medicine has identified a molecular pathway linking omega-6 linoleic acid—a common dietary fat in Western diets—to the growth of triple-negative breast cancer.

For decades, a diagnosis of metastatic breast cancer-the stage when cancer spreads beyond the breast to distant parts of the body-was often accompanied by a grim prognosis. Survival was measured in ...

The study focused on two particularly hard-to-treat breast cancer subtypes: triple-negative breast cancer and HER2-enriched breast cancer. Both forms are known for their resistance to conventional ...

Phesi’s report of the world’s most-studied diseases has become a holiday tradition, and this year’s list features few surprises. | Phesi’s report of the world’s most-studied diseases has become a ...